Abstract
Objective:
To evaluate the clinical outcomes with the use of a dual-porosity expanded polytetrafluoroethylene implant for midfacial rejuvenation.
Design:
An institutional review board–approved retrospective chart review was conducted of all patients who underwent implantation with the dual-porosity expanded polytetrafluoroethylene implant between 2001 and 2005.
Results:
A total of 170 patients, with 612 implants, were evaluated. Only 8 patients had minor complications, 3 of which necessitated implant removal. The overall results of independent observer analysis of outcomes were favorable in the majority of cases.
Conclusion:
The dual-porosity expanded polytetrafluoroethylene implant is safe and reliable to use for midfacial implantation.
Get full access to this article
View all access options for this article.
